HIF-1α and HSP90: Target molecules selected from a tumorigenic papillary thyroid carcinoma cell line

Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies

(2011) Yin Wang et al.   Cell Stem Cell

Linking Stem Cells to Thyroid Cancer

(2011) Michael Derwahl   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent

(2011) Tomohisa Horibe et al.   Journal of Translational Medicine

Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells

(2011) T. M. Yeung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and Outcomes

(2010) Iwao Sugitani et al.   WORLD JOURNAL OF SURGERY

Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005

(2009) Amy Y. Chen et al.   CANCER

Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells

(2009) Zhizhong Li et al.   CANCER CELL

mTOR Signal and Hypoxia-Inducible Factor-1  Regulate CD133 Expression in Cancer Cells

(2009) K. Matsumoto et al.   CANCER RESEARCH

Expression of hypoxia-inducible factor 1α in thyroid carcinomas

(2009) N Burrows et al.   ENDOCRINE-RELATED CANCER

An Orthotopic Model of Papillary Thyroid Carcinoma in Athymic Nude Mice

(2008) Soon-Hyun Ahn et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

International patterns and trends in thyroid cancer incidence, 1973–2002

(2008) Briseis A. Kilfoy et al.   CANCER CAUSES & CONTROL

Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

(2008) Rebecca E. Schweppe et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM